{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T19:07:54Z","timestamp":1788376074685,"version":"build-2803163510"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-36278-8","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T08:34:02Z","timestamp":1768984442000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Overcoming Candida albicans biofilm drug resistance via azole-sophorolipid synergy"],"prefix":"10.1038","volume":"16","author":[{"given":"L. A. Channa Bhathiya","family":"Jayasekara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwanrutai","family":"Watchaputi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chutikarn","family":"Butkinaree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitnipa","family":"Soontorngun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"36278_CR1","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.3390\/antibiotics11081082","volume":"11","author":"MM Aljeldah","year":"2022","unstructured":"Aljeldah, M. M. Antimicrobial resistance and its spread is a global threat. Antibiotics 11, 1082 (2022).","journal-title":"Antibiotics"},{"key":"36278_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.34016\/pjbt.2023.20.01.773","volume":"20","author":"K Ibrahim","year":"2023","unstructured":"Ibrahim, K., Saeed, A., Khalil, S. & Alam, A. Estimation of minimum inhibitory concentration of antibiotics using micro-titer plate method for native multi drug resistant gram negative bacteria. Pakistan J. Biotechnol. 20, 1\u20139 (2023).","journal-title":"Pakistan J. Biotechnol."},{"key":"36278_CR3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1146\/annurev-micro-091014-104330","volume":"69","author":"CJ Nobile","year":"2015","unstructured":"Nobile, C. J. & Johnson, A. D. Candida albicans biofilms and human disease. Annu. Rev. Microbiol. 69, 71\u201392 (2015).","journal-title":"Annu. Rev. Microbiol."},{"key":"36278_CR4","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/S1473-3099(11)70005-6","volume":"11","author":"VL Yu","year":"2011","unstructured":"Yu, V. L. Guidelines for hospital-acquired pneumonia and health-care-associated pneumonia: a vulnerability, a pitfall, and a fatal flaw. Lancet. Infect. Dis. 11, 248\u2013252. https:\/\/doi.org\/10.1016\/S1473-3099(11)70005-6 (2011).","journal-title":"Lancet. Infect. Dis"},{"key":"36278_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1099\/jmm.0.045054-0","volume":"62","author":"J Sardi","year":"2013","unstructured":"Sardi, J., Scorzoni, L., Bernardi, T., Fusco-Almeida, A. & Mendes Giannini, M. J. S. Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J. Med. Microbiol. 62, 10\u201324 (2013).","journal-title":"J. Med. Microbiol."},{"key":"36278_CR6","doi-asserted-by":"publisher","first-page":"106673","DOI":"10.1016\/j.ijantimicag.2022.106673","volume":"60","author":"F Fan","year":"2022","unstructured":"Fan, F. et al. Candida albicans biofilms: antifungal resistance, immune evasion, and emerging therapeutic strategies. Int. J. Antimicrob. Agents. 60, 106673 (2022).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"36278_CR7","doi-asserted-by":"publisher","unstructured":"Robbins, N., Wright, G. D. & Cowen, L. E. Antifungal drugs: the current armamentarium and development of new agents. Microbiol. Spectr. 4 https:\/\/doi.org\/10.1128\/microbiolspec (2016). funk-0002-2016.","DOI":"10.1128\/microbiolspec"},{"key":"36278_CR8","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1586\/14787210.2015.1032939","volume":"13","author":"D Allen","year":"2015","unstructured":"Allen, D., Wilson, D., Drew, R. & Perfect, J. Azole antifungals: 35 years of invasive fungal infection management. Expert Rev. anti-infective Therapy. 13, 787\u2013798 (2015).","journal-title":"Expert Rev. anti-infective Therapy"},{"key":"36278_CR9","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nrd.2017.46","volume":"16","author":"JR Perfect","year":"2017","unstructured":"Perfect, J. R. The antifungal pipeline: a reality check. Nat. Rev. Drug Discovery. 16, 603\u2013616 (2017).","journal-title":"Nat. Rev. Drug Discovery"},{"key":"36278_CR10","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1093\/jac\/dkx410","volume":"73","author":"NP Wiederhold","year":"2018","unstructured":"Wiederhold, N. P. et al. Fungal-specific Cyp51 inhibitor VT-1598 demonstrates in vitro activity against Candida and Cryptococcus species, endemic fungi, including Coccidioides species, Aspergillus species and Rhizopus arrhizus. J. Antimicrob. Chemother. 73, 404\u2013408 (2018).","journal-title":"J. Antimicrob. Chemother."},{"key":"36278_CR11","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1586\/14787210.2015.1056162","volume":"13","author":"K De Cremer","year":"2015","unstructured":"De Cremer, K. et al. Combinatorial drug approaches to tackle Candida albicans biofilms. Expert Rev. Anti-Infective Therapy. 13, 973\u2013984 (2015).","journal-title":"Expert Rev. Anti-Infective Therapy"},{"key":"36278_CR12","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1038\/nprot.2008.141","volume":"3","author":"CG Pierce","year":"2008","unstructured":"Pierce, C. G. et al. A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat. Protoc. 3, 1494\u20131500 (2008).","journal-title":"Nat. Protoc."},{"key":"36278_CR13","doi-asserted-by":"publisher","first-page":"4474","DOI":"10.1128\/AAC.00697-10","volume":"54","author":"S Kuchar\u00edkov\u00e1","year":"2010","unstructured":"Kuchar\u00edkov\u00e1, S. et al. In vivo efficacy of Anidulafungin against mature Candida albicans biofilms in a novel rat model of catheter-associated candidiasis. Antimicrob. Agents. 54, 4474\u20134475 (2010).","journal-title":"Antimicrob. Agents"},{"key":"36278_CR14","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1002\/jsfa.11462","volume":"102","author":"O de Caretta","year":"2022","unstructured":"de Caretta, O., Silveira, T. I., Andrade, V. A. & Macedo Jr, G. PC Celligoi, M. A. Antimicrobial activity of sophorolipids produced by Starmerella Bombicola against phytopathogens from Cherry tomato. J. Sci. Food Agric. 102, 1245\u20131254 (2022).","journal-title":"J. Sci. Food Agric."},{"key":"36278_CR15","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12934-022-01852-y","volume":"21","author":"AR Alfian","year":"2022","unstructured":"Alfian, A. R., Watchaputi, K., Sooklim, C. & Soontorngun, N. Production of new antimicrobial palm oil-derived sophorolipids by the yeast Starmerella riodocensis sp. nov. Against Candida albicans hyphal and biofilm formation. Microb. Cell. Fact. 21, 163 (2022).","journal-title":"Microb. Cell. Fact."},{"key":"36278_CR16","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3390\/pharmaceutics13020227","volume":"13","author":"Q Shu","year":"2021","unstructured":"Shu, Q., Lou, H., Wei, T., Liu, X. & Chen, Q. Contributions of glycolipid biosurfactants and glycolipid-modified materials to antimicrobial strategy: a review. Pharmaceutics 13, 227 (2021).","journal-title":"Pharmaceutics"},{"key":"36278_CR17","doi-asserted-by":"publisher","first-page":"e20180568","DOI":"10.1590\/1678-4324-2020180568","volume":"63","author":"ICC Fontoura","year":"2020","unstructured":"Fontoura, I. C. C. et al. Antibacterial activity of sophorolipids from Candida Bombicola against human pathogens. Brazilian Archives Biology. 63, e20180568 (2020).","journal-title":"Brazilian Archives Biology"},{"key":"36278_CR18","doi-asserted-by":"publisher","unstructured":"Daverey, A., Dutta, K., Joshi, S. & Daverey, A. Sophorolipid: a glycolipid biosurfactant as a potential therapeutic agent against COVID-19. Bioengineered 12, 9550\u20139560, (2021). https:\/\/doi.org\/10.1080\/21655979.2021.1997261","DOI":"10.1080\/21655979.2021.1997261"},{"key":"36278_CR19","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.jss.2010.09.013","volume":"173","author":"L Shao","year":"2012","unstructured":"Shao, L., Song, X., Ma, X., Li, H. & Qu, Y. Bioactivities of sophorolipid with different structures against human esophageal cancer cells. J. Surg. Res. 173, 286\u2013291 (2012).","journal-title":"J. Surg. Res."},{"key":"36278_CR20","doi-asserted-by":"publisher","first-page":"23575","DOI":"10.1038\/srep23575","volume":"6","author":"F Haque","year":"2016","unstructured":"Haque, F., Alfatah, M., Ganesan, K. & Bhattacharyya, M. S. Inhibitory effect of sophorolipid on Candida albicans biofilm formation and hyphal growth. Sci. Rep. 6, 23575 (2016).","journal-title":"Sci. Rep."},{"key":"36278_CR21","doi-asserted-by":"crossref","unstructured":"Ba\u011fkur, C., \u00d6zverel, C. S. & Erda\u011f, E. In Silico analysis of the synergistic interaction between biosurfactants and antifungal agents against Trichophyton spp. Cyprus J. Med. Sci. 10 (1), 16\u201319 (2025).","DOI":"10.4274\/cjms.2025.2024-118"},{"key":"36278_CR22","unstructured":"Kurtzman, C. P., Price, N. P., Ray, K. J. & Kuo, T. M. (Google Patents, (2016)."},{"key":"36278_CR23","doi-asserted-by":"publisher","unstructured":"Berkow, E. L., Lockhart, S. R. & Ostrosky-Zeichner, L. Antifungal susceptibility testing: current approaches. Clinical Microbiology Reviews 33, (2020). https:\/\/doi.org\/10.1128\/cmr. 00069\u2009\u2013\u200900019.","DOI":"10.1128\/cmr"},{"key":"36278_CR24","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.diagmicrobio.2014.03.004","volume":"79","author":"MA Pfaller","year":"2014","unstructured":"Pfaller, M. A., Castanheira, M., Messer, S. A., Rhomberg, P. R. & Jones, R. N. Comparison of EUCAST and CLSI broth microdilution methods for the susceptibility testing of 10 systemically active antifungal agents when tested against Candida spp. Diagn. Microbiol. Infect. Disease. 79, 198\u2013204 (2014).","journal-title":"Diagn. Microbiol. Infect. Disease"},{"key":"36278_CR25","doi-asserted-by":"publisher","first-page":"5385","DOI":"10.1128\/JB.183.18.5385-5394.2001","volume":"183","author":"J Chandra","year":"2001","unstructured":"Chandra, J. et al. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J. Bacteriol. 183, 5385\u20135394 (2001).","journal-title":"J. Bacteriol."},{"key":"36278_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12575-019-0106-0","volume":"21","author":"L Thieme","year":"2019","unstructured":"Thieme, L. et al. MBEC versus MBIC: the lack of differentiation between biofilm reducing and inhibitory effects as a current problem in biofilm methodology. Biol. Procedures Online. 21, 1\u20135 (2019).","journal-title":"Biol. Procedures Online"},{"key":"36278_CR27","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00253-022-12302-5","volume":"107","author":"SA Adu","year":"2023","unstructured":"Adu, S. A., Twigg, M. S., Naughton, P. J., Marchant, R. & Banat, I. M. Characterisation of cytotoxicity and Immunomodulatory effects of glycolipid biosurfactants on human keratinocytes. Appl. Microbiol. Biotechnol. 107, 137\u2013152 (2023).","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"36278_CR28","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/yea.988","volume":"20","author":"SA Lee","year":"2003","unstructured":"Lee, S. A. et al. An analysis of the Candida albicans genome database for soluble secreted proteins using computer-based prediction algorithms. Yeast 20, 595\u2013610 (2003).","journal-title":"Yeast"},{"key":"36278_CR29","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nrmicro2475","volume":"9","author":"JS Finkel","year":"2011","unstructured":"Finkel, J. S. & Mitchell, A. P. Genetic control of Candida albicans biofilm development. Nat. Rev. Microbiol. 9, 109\u2013118 (2011).","journal-title":"Nat. Rev. Microbiol."},{"key":"36278_CR30","doi-asserted-by":"publisher","first-page":"e02765","DOI":"10.1128\/spectrum.02765-21","volume":"10","author":"Y Jiang","year":"2022","unstructured":"Jiang, Y. et al. Cell cycle progression influences biofilm formation in Saccharomyces cerevisiae 1308. Microbiol. Spectr. 10, e02765\u2013e02721 (2022).","journal-title":"Microbiol. Spectr."},{"key":"36278_CR31","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jprot.2013.12.026","volume":"98","author":"K Ciesielska","year":"2014","unstructured":"Ciesielska, K. et al. Exoproteome analysis of Starmerella Bombicola results in the discovery of an esterase required for lactonization of sophorolipids. J. Proteom. 98, 159\u2013174 (2014).","journal-title":"J. Proteom."},{"key":"36278_CR32","doi-asserted-by":"crossref","unstructured":"Joshi-Navare, K. & Prabhune, A. A biosurfactant-sophorolipid acts in synergy with antibiotics to enhance their efficiency. BioMed research international 512495 (2013). (2013).","DOI":"10.1155\/2013\/512495"},{"key":"36278_CR33","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s11743-013-1495-8","volume":"17","author":"V Dengle-Pulate","year":"2014","unstructured":"Dengle-Pulate, V., Chandorkar, P., Bhagwat, S. & Prabhune, A. A. Antimicrobial and SEM studies of sophorolipids synthesized using Lauryl alcohol. J. Surfactants Detergents. 17, 543\u2013552 (2014).","journal-title":"J. Surfactants Detergents"},{"key":"36278_CR34","doi-asserted-by":"publisher","first-page":"807218","DOI":"10.3389\/fcimb.2022.807218","volume":"12","author":"YH Tartor","year":"2022","unstructured":"Tartor, Y. H. et al. Promising anti-biofilm agents and phagocytes enhancers for the treatment of Candida albicans biofilm\u2013associated infections. Front. Cell. Infect. Microbiol. 12, 807218 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"36278_CR35","doi-asserted-by":"publisher","first-page":"fuad059","DOI":"10.1093\/femsre\/fuad059","volume":"47","author":"J Massey","year":"2023","unstructured":"Massey, J., Zarnowski, R. & Andes, D. Role of the extracellular matrix in Candida biofilm antifungal resistance. FEMS Microbiol. Rev. 47, fuad059 (2023).","journal-title":"FEMS Microbiol. Rev."},{"key":"36278_CR36","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jbiotec.2019.12.019","volume":"309","author":"C Ceresa","year":"2020","unstructured":"Ceresa, C., Fracchia, L., Williams, M., Banat, I. & De Rienzo, M. D. The effect of sophorolipids against microbial biofilms on medical-grade silicone. J. Biotechnol. 309, 34\u201343 (2020).","journal-title":"J. Biotechnol."},{"key":"36278_CR37","unstructured":"Herrick, E. J., Patel, P. & Hashmi, M. F. in StatPearlsStatPearls Publishing, (2024)."},{"key":"36278_CR38","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1128\/AAC.46.6.1773-1780.2002","volume":"46","author":"D Kuhn","year":"2002","unstructured":"Kuhn, D., George, T., Chandra, J., Mukherjee, P. & Ghannoum, M. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob. Agents Chemother. 46, 1773\u20131780 (2002).","journal-title":"Antimicrob. Agents Chemother."},{"key":"36278_CR39","doi-asserted-by":"publisher","first-page":"6411","DOI":"10.1021\/acs.langmuir.0c00643","volume":"36","author":"BV Nguyen","year":"2020","unstructured":"Nguyen, B. V., Nagakubo, T., Toyofuku, M., Nomura, N. & Utada, A. S. Synergy between sophorolipid biosurfactant and SDS increases the efficiency of P. aeruginosa biofilm disruption. Langmuir 36, 6411\u20136420 (2020).","journal-title":"Langmuir"},{"key":"36278_CR40","doi-asserted-by":"publisher","first-page":"4454","DOI":"10.1002\/jmv.26917","volume":"93","author":"E Van Damme","year":"2021","unstructured":"Van Damme, E. et al. In vitro activity of Itraconazole against SARS-CoV\u20102. J. Med. Virol. 93, 4454\u20134460 (2021).","journal-title":"J. Med. Virol."},{"key":"36278_CR41","first-page":"62","volume":"50","author":"H Turan","year":"2018","unstructured":"Turan, H. & Demirbilek, M. Biofilm-forming capacity of blood\u2013borne Candida albicans strains and effects of antifungal agents. Rev. Argent. Microbiol. 50, 62\u201369 (2018).","journal-title":"Rev. Argent. Microbiol."},{"key":"36278_CR42","doi-asserted-by":"publisher","first-page":"284","DOI":"10.4103\/ijd.IJD_548_19","volume":"65","author":"SK Singh","year":"2020","unstructured":"Singh, S. K., Subba, N. & Tilak, R. Efficacy of terbinafine and Itraconazole in different doses and in combination in the treatment of Tinea infection: a randomized controlled parallel group open labeled trial with clinico-mycological correlation. Indian J. Dermatology. 65, 284\u2013289 (2020).","journal-title":"Indian J. Dermatology"},{"key":"36278_CR43","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.2217\/fmb.13.101","volume":"8","author":"HT Taff","year":"2013","unstructured":"Taff, H. T., Mitchell, K. F., Edward, J. A. & Andes, D. R. Mechanisms of Candida biofilm drug resistance. Future Microbiol. 8, 1325\u20131337 (2013).","journal-title":"Future Microbiol."},{"key":"36278_CR44","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.nbt.2015.02.009","volume":"32","author":"MAD De Rienzo","year":"2015","unstructured":"De Rienzo, M. A. D., Banat, I. M., Dolman, B., Winterburn, J. & Martin, P. J. Sophorolipid biosurfactants: possible uses as antibacterial and antibiofilm agent. New Biotechnol. 32, 720\u2013726 (2015).","journal-title":"New Biotechnol."},{"key":"36278_CR45","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1248\/bpbreports.7.2_56","volume":"7","author":"M Araki","year":"2024","unstructured":"Araki, M. et al. The lower toxicity and wider safety range of acidic sophorolipid compared to surfactin and rhamnolipid as biosurfactants toward the HaCAT, THP-1, and RAW 264.7. BPB Rep. 7, 56\u201360 (2024).","journal-title":"BPB Rep."},{"key":"36278_CR46","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1128\/EC.00026-12","volume":"11","author":"BL Granger","year":"2012","unstructured":"Granger, B. L. Insight into the antiadhesive effect of yeast wall protein 1 of Candida albicans. Eukaryot. Cell. 11, 795\u2013805 (2012).","journal-title":"Eukaryot. Cell"},{"key":"36278_CR47","doi-asserted-by":"publisher","first-page":"e1012865","DOI":"10.1371\/journal.ppat.1012865","volume":"21","author":"Y Zhao","year":"2025","unstructured":"Zhao, Y. et al. Systemic infection by Candida albicans requires FASN-\u03b1 subunit induced cell wall remodeling to perturb immune response. PLoS Pathog. 21, e1012865 (2025).","journal-title":"PLoS Pathog."},{"key":"36278_CR48","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1574-6968.2002.tb11330.x","volume":"214","author":"G Ramage","year":"2002","unstructured":"Ramage, G., VandeWalle, K., L\u00f3pez-Ribot, J. L. & Wickes, B. L. The filamentation pathway controlled by the Efg1 regulator protein is required for normal biofilm formation and development in Candida albicans. FEMS Microbiol. Lett. 214, 95\u2013100 (2002).","journal-title":"FEMS Microbiol. Lett."},{"key":"36278_CR49","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1111\/j.1462-5822.2012.01813.x","volume":"14","author":"IV Ene","year":"2012","unstructured":"Ene, I. V. et al. Host carbon sources modulate cell wall architecture, drug resistance and virulence in a fungal pathogen. Cell. Microbiol. 14, 1319\u20131335 (2012).","journal-title":"Cell. Microbiol."},{"key":"36278_CR50","doi-asserted-by":"publisher","first-page":"3629","DOI":"10.1099\/mic.0.26640-0","volume":"149","author":"CJ Nobile","year":"2003","unstructured":"Nobile, C. J., Bruno, V. M., Richard, M. L., Davis, D. A. & Mitchell, A. P. Genetic control of chlamydospore formation in Candida albicans. Microbiology 149, 3629\u20133637 (2003).","journal-title":"Microbiology"},{"key":"36278_CR51","doi-asserted-by":"publisher","unstructured":"Uppuluri, P. et al. Candida albicans dispersed cells are developmentally distinct from biofilm and planktonic cells. MBio 9, e01338. https:\/\/doi.org\/10.1128\/mbio.01338-18 (2018).","DOI":"10.1128\/mbio.01338-18"},{"key":"36278_CR52","doi-asserted-by":"publisher","first-page":"20405","DOI":"10.1038\/s41598-025-08816-3","volume":"15","author":"K Watchaputi","year":"2025","unstructured":"Watchaputi, K. et al. Yeast-derived glycolipids disrupt Candida biofilm and inhibit expression of genes in cell adhesion. Sci. Rep. 15, 20405 (2025).","journal-title":"Sci. Rep."},{"key":"36278_CR53","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/jam.14949","volume":"131","author":"R Pereira","year":"2021","unstructured":"Pereira, R., dos Santos Fontenelle, R. O., De Brito, E. & De Morais, S. Biofilm of Candida albicans: formation, regulation and resistance. J. Appl. Microbiol. 131, 11\u201322 (2021).","journal-title":"J. Appl. Microbiol."},{"key":"36278_CR54","doi-asserted-by":"crossref","unstructured":"Wang, D. et al. Fungal biofilm formation and its regulatory mechanism. Heliyon 10 (12), e32766  (2024).","DOI":"10.1016\/j.heliyon.2024.e32766"},{"key":"36278_CR55","first-page":"163","volume":"18","author":"G Ramage","year":"2001","unstructured":"Ramage, G., Walle, K., Wickes, B. L. & L\u00f3pez-Ribot, J. L. Characteristics of biofilm formation by Candida albicans. Revista Iberoamericana De micolog\u00eda. 18, 163\u2013170 (2001).","journal-title":"Revista Iberoamericana De micolog\u00eda"},{"key":"36278_CR56","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/jctb.5847","volume":"94","author":"H Wang","year":"2019","unstructured":"Wang, H. et al. Starmerella bombicola: recent advances on sophorolipid production and prospects of waste stream utilization. J. Chem. Technol. Biotechnol. 94, 999\u20131007 (2019).","journal-title":"J. Chem. Technol. Biotechnol."},{"key":"36278_CR57","doi-asserted-by":"publisher","first-page":"118089","DOI":"10.1016\/j.indcrop.2024.118089","volume":"210","author":"E Taowkrue","year":"2024","unstructured":"Taowkrue, E., Songdech, P., Maneerat, S. & Soontorngun, N. Enhanced production of yeast biosurfactant sophorolipids using yeast extract or the alternative nitrogen source soybean meal. Industrial Crops Prod. 210, 118089 (2024).","journal-title":"Industrial Crops Prod."},{"key":"36278_CR58","doi-asserted-by":"publisher","first-page":"100027","DOI":"10.1016\/j.clet.2020.100027","volume":"1","author":"JH Kim","year":"2020","unstructured":"Kim, J. H. et al. Value-added conversion of biodiesel into the versatile biosurfactant sophorolipid using Starmerella Bombicola. Clean. Eng. Technol. 1, 100027 (2020).","journal-title":"Clean. Eng. Technol."},{"key":"36278_CR59","doi-asserted-by":"publisher","first-page":"18233","DOI":"10.1038\/s41598-025-03061-0","volume":"15","author":"P Songdech","year":"2025","unstructured":"Songdech, P. et al. Elucidating a novel metabolic pathway for enhanced antimicrobial glycolipid biosurfactant production in the yeast Meyerozyma guilliermondii. Sci. Rep. 15, 18233 (2025).","journal-title":"Sci. Rep."},{"key":"36278_CR60","doi-asserted-by":"publisher","first-page":"9724","DOI":"10.1038\/s41598-023-36191-4","volume":"13","author":"K Watchaputi","year":"2023","unstructured":"Watchaputi, K., Jayasekara, L. C. B., Ratanakhanokchai, K. & Soontorngun, N. Inhibition of cell cycle-dependent hyphal and biofilm formation by a novel cytochalasin 19, 20\u2013epoxycytochalasin Q in Candida albicans. Sci. Rep. 13, 9724 (2023).","journal-title":"Sci. Rep."},{"key":"36278_CR61","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1093\/jac\/dkae233","volume":"79","author":"N Fatsis-Kavalopoulos","year":"2024","unstructured":"Fatsis-Kavalopoulos, N., S\u00e1nchez-Hevia, D. L. & Andersson, D. I. Beyond the FIC index: the extended information from fractional inhibitory concentrations (FICs). J. Antimicrob. Chemother. 79, 2394\u20132396 (2024).","journal-title":"J. Antimicrob. Chemother."},{"key":"36278_CR62","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.cll.2019.04.002","volume":"39","author":"T Brennan-Krohn","year":"2019","unstructured":"Brennan-Krohn, T. & Kirby, J. E. When one drug is not enough: context, methodology, and future prospects in antibacterial synergy testing. Clin. Lab. Med. 39, 345 (2019).","journal-title":"Clin. Lab. Med."},{"key":"36278_CR63","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1093\/nar\/18.10.3091","volume":"18","author":"ME Schmitt","year":"1990","unstructured":"Schmitt, M. E., Brown, T. A. & Trumpower, B. L. A rapid and simple method for Preparation of RNA from Saccharomyces cerevisiae. Nucleic Acids Res. 18, 3091 (1990).","journal-title":"Nucleic Acids Res."},{"key":"36278_CR64","doi-asserted-by":"crossref","unstructured":"Juanes, M. A. Methods of synchronization of yeast cells for the analysis of cell cycle progression. Methods Mol. Biol. 1505, 19\u201334 (2016).","DOI":"10.1007\/978-1-4939-6502-1_2"},{"key":"36278_CR65","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1534\/g3.120.401340","volume":"10","author":"O Kuloyo","year":"2020","unstructured":"Kuloyo, O., Fourie, R., Cason, E., Albertyn, J. & Pohl, C. H. Transcriptome analyses of Candida albicans biofilms, exposed to arachidonic acid and fluconazole, indicates potential drug targets. G3: Genes Genomes Genet. 10, 3099\u20133108 (2020).","journal-title":"G3: Genes Genomes Genet."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36278-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36278-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36278-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T11:04:39Z","timestamp":1770894279000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36278-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["36278"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-36278-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"assertion":[{"value":"20 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5963"}}